Intraperitoneal pharmacokinetics of vancomycin in patients on automated peritoneal dialysis-Reference-Cited by-同舟云学术

Intraperitoneal pharmacokinetics of vancomycin in patients on automated peritoneal dialysis

Author:

Lam Edwin¹²,Ting (Kayla) Lien Yi³,Kraft Walter K.²,Stickle Douglas F.⁴,Piraino Beth⁵,Zhang Jingjing⁶

Affiliation:

1. Clinical Pharmacokinetics Research Lab National Institutes of Health Bethesda Maryland USA

2. Department of Pharmacology & Experimental Therapeutics Thomas Jefferson University Philadelphia Pennsylvania USA

3. Center for Pharmacometrics and Systems Pharmacology College of Pharmacy University of Florida Orlando Florida USA

4. Department of Pathology Thomas Jefferson University Philadelphia Pennsylvania USA

5. Renal Electrolyte Division School of Medicine University of Pittsburgh Pittsburgh Pennsylvania USA

6. Division of Nephrology Department of Medicine Thomas Jefferson University Philadelphia Pennsylvania USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

Reference10 articles.

1. System.USRDS annual data report: epidemiology of kidney disease in the United States;2020.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Vancomycin flushing reaction after intraperitoneal vancomycin: A case report;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2023-09-25

3. Inconsistencies in 2022 ISPD peritonitis guidelines;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2023-05

4. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2022-03